Skip to main content
. 2021 Mar 26;12:647728. doi: 10.3389/fimmu.2021.647728

Figure 1.

Figure 1

HIV PIs alter cathepsins’ activity in human macrophages infected with Mtb. (A) Omnicathepsin activity or cathepsin S activity alone were monitored with a specific fluorogenic substrate every 5 min in live cells pretreated with DMSO, RTV, SQV, or with specific inhibitors (E-64d or ZFL-COCHOO for cathepsin S). The slope of fluorescence emission in the presence of DMSO was represented as 100%, and the effect of each PI was calculated as a percentage of the DMSO control. Data are represented as average from three independent experiments and donors and data dispersion represented by the error bars as standard error (*P < 0.05, **P < 0.01, ***P < 0.001 relatively to control). (B) Cell viability (upper bar-plots) was measured in non-infected cells treated for 3 days with the PIs and using PrestoBlue resazurin-based solution by quantifying the emission of fluorescence in a plate reader. Cell death (lower bar-plot) was measured by flow cytometry after 24 h of infection using FITC-Annexin V and propidium iodide. Values show the average of three biological replicates from one representative experiment performed in triplicate while error bars depict standard deviation (*P < 0.05, **P < 0.001 relatively to control).